New Zealand markets closed

AstraZeneca PLC (ZEG.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
140.45-1.80 (-1.27%)
At close: 05:19PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
49,133,000
45,811,000
44,351,000
37,417,000
26,617,000
Cost of revenue
8,804,000
8,268,000
12,391,000
12,437,000
5,299,000
Gross profit
40,329,000
37,543,000
31,960,000
24,980,000
21,318,000
Operating expenses
Research development
11,448,000
10,935,000
9,762,000
9,736,000
5,991,000
Selling general and administrative
18,603,000
18,222,000
17,984,000
15,590,000
11,896,000
Total operating expenses
30,751,000
28,821,000
27,448,000
25,119,000
17,402,000
Operating income or loss
9,578,000
8,722,000
4,512,000
-139,000
3,916,000
Interest expense
1,650,000
1,589,000
1,330,000
1,276,000
1,272,000
Income before tax
7,746,000
6,899,000
2,501,000
-265,000
3,916,000
Income tax expense
1,301,000
938,000
-792,000
-380,000
772,000
Income from continuing operations
6,445,000
5,961,000
3,293,000
115,000
3,144,000
Net income
6,440,000
5,955,000
3,288,000
112,000
3,196,000
Net income available to common shareholders
6,440,000
5,955,000
3,288,000
112,000
3,196,000
Basic EPS
3.80
3.84
2.12
0.08
2.44
Diluted EPS
3.78
3.81
2.11
0.08
2.44
Basic average shares
1,548,750
1,549,000
1,548,000
1,418,000
1,312,000
Diluted average shares
1,560,000
1,562,000
1,560,000
1,427,000
1,313,000